文献速递心血管MR

心脏磁共振成像衍生的心肌纤维化参数对肥厚型心肌病患者风险分层的价值

The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
PubMed 文献 · Acad Radiol · 2023-01-03

回顾性纳入108例肥厚型心肌病患者,随访2年记录心脏性猝死不良事件,按2020 AHA/ACC指南风险因素分为低危和高危组。全局ECV是唯一预测SCD风险的心肌纤维化参数,其AUC高于LGE、全局原生T1、全局增强后T1和HCM Risk-SCD评分。联合全局ECV与HCM Risk-SCD评分的整合模型在训练队列AUC为0.89,验证队列为0.93。

要点

  • 全局ECV是唯一预测SCD风险的心肌纤维化参数(p<0.001)。
  • 全局ECV的AUC为0.85,高于LGE、全局原生T1、全局增强后T1和HCM Risk-SCD评分。
  • 整合模型联合全局ECV与HCM Risk-SCD评分,训练队列AUC为0.89,验证队列AUC为0.93。

核心结论

  • 心脏磁共振衍生的ECV在预测肥厚型心肌病患者SCD风险分层方面与HCM Risk-SCD量表相当。

研究设计与样本

  • 回顾性研究,纳入2019年1月至2022年4月的108例肥厚型心肌病患者,随访2年记录SCD不良事件;所有患者行心脏MRI,分为训练队列81例和验证队列27例;按2020 AHA/ACC指南定义的SCD风险因素分为低危和高危组。

关键影像表现/征象

  • 评估了心脏MRI特征包括延迟钆增强(LGE)、T1 mapping和细胞外容积分数(ECV),并在低危和高危组间比较。
  • 全局ECV是唯一预测SCD风险的心肌纤维化参数(p<0.001)。

诊断标准与关键数值

  • 全局ECV预测SCD风险的AUC为0.85,高于LGE的0.74、全局原生T1的0.77、全局增强后T1的0.63和HCM Risk-SCD的0.78。
  • 整合模型(全局ECV比值比1.36 [95%CI: 1.16-1.60],p<0.001;HCM Risk-SCD评分比值比1.63 [95%CI: 1.08-2.47],p<0.001)在训练队列AUC为0.89(95%CI: 0.81-0.96),显著高于单独HCM Risk-SCD评分(p=0.03);验证队列AUC为0.93(95%CI: 0.84-1.00)。
  • 多因素Cox回归显示全局ECV是SCD不良事件的独立预测因子(风险比1.27 [95%CI: 1.10-1.47])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The aim of the study was to determine whether myocardial fibrosis parameters of cardiac magnetic resonance imaging (MRI) has added value in the risk stratification of hypertrophic cardiomyopathy (HCM) patients.

MATERIALS AND METHODS: In this retrospective study, 108 patients with HCM (mean age ± standard deviation, 55.5 ± 13.4 years) were included from January 2019 to April 2022, and were followed up for 2 years to record sudden cardiac death (SCD) adverse events. All HCM patients underwent cardiac MRI and were divided into a training cohort (n = 81; mean age, 56.1 ± 13.0 years) and a validation cohort (n = 27; mean age, 57.8 ± 13.9 years). According to the presence of SCD risk factors defined by the 2020 AHA/ACC guidelines, HCM patients were classified into low-risk and high-risk groups. Cardiac MRI features, including late gadolinium enhancement (LGE), T1 mapping, and extracellular volume fraction (ECV), were assessed and compared between the two groups. Logistic regression analysis was used to select the optimal predictors of SCD from cardiac MRI features and HCM Risk-SCD score to construct prediction models. Receiver operating curve (ROC) analysis was used to assess the predictive performance of the constructed prediction model. Cox regression analysis was also used to determine the optimal predictors of SCD adverse events.

RESULTS: Multivariate logistic analysis showed that the global ECV was the single myocardial fibrosis parameter predictive of the risk of SCD (p < 0.001). The areas under the ROC curves (AUC) of global ECV were higher than those of LGE, global native T1, global postcontrast T1, and HCM Risk-SCD (AUC = 0.85 vs. 0.74, 0.77, 0.63, 0.78). An integrative risk stratification model combining global ECV (odds ratio, 1.36 [95% CI: 1.16-1.60]; p < 0.001) and HCM Risk-SCD score (odds ratio, 1.63 [95% CI: 1.08-2.47]; p < 0.001) achieved an AUC of 0.89 (95% CI: 0.81-0.96) in the training cohort, which was significantly higher than that of HCM Risk-SCD score alone (p = 0.03). The AUC of the integrative model was 0.93 (95% CI: 0.84-1.00) in the validation cohort. Multivariate Cox regression analysis also showed that the global ECV was an independent predictor of SCD adverse events (hazard ratio, 1.27 [95% CI: 1.10-1.47]).

CONCLUSION: The ECV derived from cardiac MRI is comparable to the HCM Risk-SCD scale in predicting the SCD risk stratification in patients with HCM.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yu T, Cai Z, Yang Z, et al. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy. Acad Radiol. 2023. PMID: 36604228. doi:10.1016/j.acra.2022.12.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。